Venkatesh, D.* ; O'Brien, N.A.* ; Zandkarimi, F.* ; Tong, D.R.* ; Stokes, M.E.* ; Dunn, D.E.* ; Kengmana, E.S.* ; Aron, A.T.* ; Klein, A.M.* ; Csuka, J.M.* ; Moon, S.H.* ; Conrad, M. ; Chang, C.J.* ; Lo, D.C.* ; D'Alessandro, A.* ; Prives, C.* ; Stockwell, B.R.*
MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling.
Genes Dev. 34, 526-543 (2020)
MDM2 and MDMX, negative regulators of the tumor suppressor p53, can work separately and as a heteromeric complex to restrain p53's functions. MDM2 also has pro-oncogenic roles in cells, tissues, and animals that are independent of p53. There is less information available about p53-independent roles of MDMX or the MDM2-MDMX complex. We found that MDM2 and MDMX facilitate ferroptosis in cells with or without p53. Using small molecules, RNA interference reagents, and mutant forms of MDMX, we found that MDM2 and MDMX, likely working in part as a complex, normally facilitate ferroptotic death. We observed that MDM2 and MDMX alter the lipid profile of cells to favor ferroptosis. Inhibition of MDM2 or MDMX leads to increased levels of FSP1 protein and a consequent increase in the levels of coenzyme Q(10), an endogenous lipophilic antioxidant. This suggests that MDM2 and MDMX normally prevent cells from mounting an adequate defense against lipid peroxidation and thereby promote ferroptosis. Moreover, we found that PPAR alpha activity is essential for MDM2 and MDMX to promote ferroptosis, suggesting that the MDM2-MDMX complex regulates lipids through altering PPAR alpha activity. These findings reveal the complexity of cellular responses to MDM2 and MDMX and suggest that MDM2-MDMX inhibition might be useful for preventing degenerative diseases involving ferroptosis. Furthermore, they suggest that MDM2/MDMX amplification may predict sensitivity of some cancers to ferroptosis inducers.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Ferroptosis ; Mdm2 ; Mdmx ; P53-independent ; Ppar Alpha ; Lipid Metabolism ; Fsp1 ; Coq(10) ; Cancer; Proliferator-activated Receptor; Cell-death; P53; Metabolism; Inhibitors; Identification; Oxidation; Apoptosis; Complex; Target
Keywords plus
Language
english
Publication Year
2020
Prepublished in Year
HGF-reported in Year
2020
ISSN (print) / ISBN
0890-9369
e-ISSN
1549-5477
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 34,
Issue: 7-8,
Pages: 526-543
Article Number: ,
Supplement: ,
Series
Publisher
Cold Spring Harbor Laboratory Press
Publishing Place
1 Bungtown Rd, Cold Spring Harbor, Ny 11724 Usa
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-506900-001
Grants
Copyright
Erfassungsdatum
2020-04-20